Market Cap

SyneuRx International Market Capitalization:

TW$2.11 Billion

TWD as of Jan. 1, 2024

US$68.8 Million

business SyneuRx International Company Profile

SyneuRx International Main Stock Listing

TWSE: 6575

Market Capitalization History of SyneuRx International

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of SyneuRx International market cap

Date Market Cap YoY Change
Jan. 1, 2024 TW$2.11 B -70.89%
Jan. 1, 2022 TW$7.25 B 37.57%
Jan. 1, 2021 TW$5.27 B -13.37%
Jan. 1, 2020 TW$6.08 B -17.56%
Jan. 1, 2019 TW$7.38 B 14.00%
Jan. 1, 2018 TW$6.47 B -43.60%
Jan. 1, 2017 TW$11.48 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

SyneuRx International Categories

Taiwan languages Healthcare languages Biotechnology
Taiwan Healthcare Taiwan Biotechnology

Stocks & Indices

SyneuRx International has the following listings and related stock indices.


Stock: TWSE: 6575

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.